GSK706769 Repeat Dose Study

Clinical trial NCT00711386 · COMPLETED

Trial details

NCT number: NCT00711386
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus

Start date: 2008-05-16
Primary completion: 2008-09-12
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.